AdvaMed Comments to HHS Deregulation RFI
AdvaMed submitted public comments in response to HHS’s request for information on eliminating federal regulations that hinder economic growth, innovation, and American competitiveness.
AdvaMed Response to House Privacy Working Group RFI
AdvaMed calls for federal privacy laws that reflect how medical devices use patient data differently from consumer health tools.
AdvaMed Comments to DOJ Anticompetitive Regulations RFC
AdvaMed urges DOJ to remove outdated rules that block medtech innovation and limit access to lifesaving technology.
AdvaMed® Comment Letter to OIG’s Annual Solicitation for Safe Harbors and Special Fraud Alerts
AdvaMed urges OIG to modernize Anti-Kickback Statute safe harbors and issue a new fraud alert to support value-based care and expand access to medical technologies.
AdvaMed® Recommendations to CMS Regarding Sunshine Reporting Audits
AdvaMed®, the world’s leading medtech trade association, communicated to Centers for Medicaid & Medicare Services (CMS) recommendations regarding administration of the Open Payments program.
AdvaMed® Response to Senate HELP Committee Regarding Reauthorization of Pandemic All-Hazards Preparedness Act
On March 29, AdvaMed® responded to the Senate HELP Committee’s request for information on policy priorities for the reauthorization of the Pandemic All-Hazards Preparedness Act (PAHPA).
AdvaMed® Comment Letter to OIG – January 27, 2023
AdvaMed® responded to HHS OIG’s annual solicitation of proposals for new and modified safe harbors and special fraud alerts.
Letter to the Editor: Article on Device Sterilization Didn’t Provide the Complete Picture
Lucy Fraiser, Ph.D., a board-certified toxicologist, recently responded in a letter to the editor of Modern Healthcare about the publication’s recent coverage of the EPA’s work on ethylene oxide.
AdvaMed® Submits Comments on CY 2023 OPPS/ASC Proposed Rule
AdvaMed® submitted comments to CMS on the CY 2023 Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center Payment System proposed rule.
AdvaMed® Submits Comments on the CY 2023 PFS Proposed Rule
AdvaMed® submitted comments to CMS on the Calendar Year 2023 Physician Fee Schedule (PFS) proposed rule.